• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Repligen Corp (NQ: RGEN )

    140.70 -3.18 (-2.21%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Repligen Corp

    < Previous 1 2 3 4 5 6 Next >
    Repligen Corp. (NASDAQ: RGEN) is a Leading Gainer in 10/31 Morning Trading
    Via Investor Brand Network
    Earnings Scheduled For October 31, 2023
    Companies Reporting Before The Bell • BBVA (NYSE:BBVA) is likely to report earnings for its third quarter. • BP (NYSE:BP) is expected to report quarterly earnings at $1.37 per share on revenue of... 
    Via Benzinga
    A Preview Of Repligen's Earnings
    Via Benzinga
    7 Analysts Have This to Say About Repligen
    Via Benzinga
    What 6 Analyst Ratings Have To Say About Repligen
    Via Benzinga
    What 4 Analyst Ratings Have To Say About Repligen
    Via Benzinga
    Looking Into Repligen's Return On Capital Employed
    Via Benzinga
    Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Gainers Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholders approved its proposed business combination with DLQ. 
    Via Benzinga
    Reviewing Mailbag Items and 5 Stocks Indistinguishable From Magic
    September wasn't a good month for the stock market, but there's plenty for investors to talk about. 
    Via The Motley Fool
    Why Repligen Stock Is Sinking Today
    Investors appear to be anticipating an underwhelming first-quarter report from the bioprocessing company. 
    Via The Motley Fool
    Why Shares of Repligen Rose This Week
    The company is coming off a solid third quarter and is getting noticed by analysts. 
    Via The Motley Fool
    Despite Attractive End Markets, Analyst Outlines Concerns For Repligen Stock
    Via Benzinga
    Life Sciences Player Repligen's Strategic European Acquisition - What It Means for Investors
    Repligen Corporation (NASDAQ: RGEN) agreed to acquire Sweden-based privately-held Metenova.  
    Via Benzinga
    Humana, Waters, e.l.f. Beauty, Teva Pharmaceutical And Other Big Stocks Moving Higher On Wednesday
    U.S. stocks traded lower, with the Dow Jones falling around 200 points on Wednesday. Here are some big stocks recording gains in today’s session. Powell Industries, Inc. (NASDAQ: POWL) shares jumped... 
    Via Benzinga
    Top 5 Health Care Stocks That May Collapse In July
    The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
    Via Benzinga
    Over $6M Bet On This Financial Services Stock? Check Out These 3 Stocks Insiders Are Buying
    Although US stocks closed mixed on Monday, there were a few notable insider trades. 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2023
    Via Benzinga
    Repligen Expects Slower Growth In APAC, Builds Portfolio On Heels Of FlexBiosys Deal
    Repligen Corp (NASDAQ: RGEN) reported Q1 FY23 sales of $182.66 million, down 12% Y/Y as reported,  
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2023
    Via Benzinga
    This Analyst Is Bullish on Repligen's FlexBiosys Acquisition for Fluid Management Portfolio
    Repligen Inc (NASDAQ: RGEN) agreed to acquire FlexBiosys Inc to build its Fluid Management franchise and add a full range of single-use bioprocessing bags and assemblies.  
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For March 28, 2023
    Via Benzinga
    Earnings Scheduled For February 22, 2023
    Companies Reporting Before The Bell • Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022. 
    Via Benzinga
    Catalent Hits Four-Month High As Danaher Reportedly Mulls A Takeover
    Danaher is reportedly looking to add to its wheelhouse to compete with Thermo. 
    Via Investor's Business Daily
    Dada Nexus, Bilibili And Other Big Stocks Moving Lower On Monday
    U.S. stocks traded lower, with the Nasdaq Composite dropping over 100 points on Monday. Here are some big stocks recording losses in today’s session. 
    Via Benzinga
    Repligen Earnings Perspective: Return On Capital Employed
    Pulled from Benzinga Pro data, Repligen (NASDAQ:RGEN) posted Q3 earnings of $40.41 million, an increase from Q2 of 18.96%. Sales dropped to $200.74 million, a 3.32% decrease between quarters. 
    Via Benzinga
    Recap: Repligen Q3 Earnings
    Repligen (NASDAQ:RGEN) reported its Q3 earnings results on Tuesday, November 1, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings Repligen beat estimated earnings by... 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
    Via Benzinga
    Earnings Scheduled For November 1, 2022
    Companies Reporting Before The Bell • BP (NYSE:BP) is estimated to report quarterly earnings at $2.07 per share on revenue of $64.76 billion. 
    Via Benzinga
    Why Olaplex Shares Dipped Around 57%; Here Are 75 Biggest Movers From Yesterday
    Gainers Amprius Technologies, Inc. (NYSE: AMPX) jumped 77.3% to settle at $11.01 on Wednesday after the company announced it was awarded a $50 million cost-sharing grant from the U.S. Department of... 
    Via Benzinga
    Why United Airlines Shares Are Trading Higher? Here Are 43 Stocks Moving In Wednesday's Mid-Day Session
    Gainers SenesTech, Inc. (NASDAQ: SNES) shares jumped 102.6% to $0.47 after declining over 3% on Tuesday. SenesTech, during August, posted a Q2 loss of $0.21 per share. 
    Via Benzinga
    < Previous 1 2 3 4 5 6 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.